Financhill
Buy
77

TYG Quote, Financials, Valuation and Earnings

Last price:
$43.89
Seasonality move :
-0.96%
Day range:
$43.73 - $44.55
52-week range:
$28.01 - $46.35
Dividend yield:
7.62%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
122.5K
Avg. volume:
67.3K
1-year change:
48.8%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Period Ending 2017-11-30 2018-11-30 2019-11-30 2020-11-30 2021-11-30
Revenue -$121.6M $80.2M -$185.1M -$568.1M $136.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.8M $1.7M $1.6M $1.3M $1.1M
Other Inc / (Exp) $119.3M $42.6M $29.1M -$632.5M $24.4M
Operating Expenses $9.1M $8.6M $8.9M $9.9M $2.6M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$130.7M $71.7M -$194.1M -$578M $133.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$17.3M -$24.7M -$2.7M -$2.2M --
Net Income to Company -$113.4M $96.4M -$191.4M -$575.7M $133.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$113.4M $96.4M -$191.4M -$575.7M $133.7M
 
Basic EPS (Cont. Ops) -$9.16 $8.40 -$14.28 -$42.11 $11.31
Diluted EPS (Cont. Ops) -$9.16 $8.40 -$14.28 -$42.11 $11.31
Weighted Average Basic Share $12.4M $11.5M $13.4M $13.7M $11.8M
Weighted Average Diluted Share $12.4M $11.5M $13.4M $13.7M $11.8M
 
EBITDA -- -- -- -- --
EBIT -$113.1M $90.2M -$175.6M -$570M $137.6M
 
Revenue (Reported) -$121.6M $80.2M -$185.1M -$568.1M $136.4M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -$113.1M $90.2M -$175.6M -$570M $137.6M
Period Ending 2021-01-11 2022-01-11 2023-01-11 2024-01-11
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2021-01-11 2022-01-11 2023-01-11 2024-01-11
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2015-01-11 2016-01-11 2017-01-11 2018-01-11 2019-01-11
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2017-11-30 2018-11-30 2019-11-30 2020-11-30 2021-11-30
Cash and Equivalents -- -- -- -- --
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $883.4K $751.2K $843.2K $680.6K $871.4K
Other Current Assets -- -- -- -- --
Total Current Assets $10.2M $1.4M $4.6M $1.7M $9.3M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments $2.2B $2.1B $1.7B $402.1M $560M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $2.2B $2.1B $1.7B $455.8M $569.2M
 
Accounts Payable $11.5M $23.2M -- $585.3K $9.3M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $15.2M $26.9M $2.9M $14.5M $16.9M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $1.1B $876M $750.5M $150.2M $154.3M
 
Common Stock $49.4K $53.6K $53.7K $12.3K $11.9K
Other Common Equity Adj -- -- -- -- --
Common Equity $1.2B $1.3B $930.3M $305.6M $414.9M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $1.2B $1.3B $930.3M $305.6M $414.9M
 
Total Liabilities and Equity $2.2B $2.1B $1.7B $455.8M $569.2M
Cash and Short Terms -- -- -- -- --
Total Debt -- -- -- -- --
Period Ending 2017-11-30 2018-11-30 2019-11-30 2020-11-30 2021-11-30
Cash and Equivalents -- -- -- -- --
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- $751.2K $843.2K $680.6K $871.4K
Other Current Assets -- -- -- -- --
Total Current Assets -- $1.4M $4.6M $1.7M $9.3M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- $2.1B $1.7B $402.1M $560M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- $2.1B $1.7B $455.8M $569.2M
 
Accounts Payable -- $23.2M -- $585.3K $9.3M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- $26.9M $2.9M $14.5M $16.9M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- $876M $750.5M $150.2M $154.3M
 
Common Stock -- $53.6K $53.7K $12.3K $11.9K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- $1.3B $930.3M $305.6M $414.9M
 
Total Liabilities and Equity -- $2.1B $1.7B $455.8M $569.2M
Cash and Short Terms -- -- -- -- --
Total Debt -- -- -- -- --
Period Ending 2017-11-30 2018-11-30 2019-11-30 2020-11-30 2021-11-30
Net Income to Stockholders -$113.4M $96.4M -$191.4M -$575.7M $133.7M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$12.2M $7M $1.2M -$38.8M $44.7M
Change in Inventories -- -- -- -- --
Cash From Operations $144.1M $55.6M $166.8M $538.8M $23M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -$121.9M -$131.8M -$138.6M -$28.9M -$17.5M
Special Dividend Paid
Long-Term Debt Issued -$26.6M -$38.1M -$28.2M -- $6M
Long-Term Debt Repaid -- -- -- -$357.8M -$4M
Repurchase of Common Stock -- -- -- -$152.1M -$7.5M
Other Financing Activities $180 -- -- -- --
Cash From Financing -$144.1M -$55.6M -$166.8M -$538.8M -$23M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-01-11 2022-01-11 2023-01-11 2024-01-11
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-01-11 2022-01-11 2023-01-11 2024-01-11
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2015-01-11 2016-01-11 2017-01-11 2018-01-11 2019-01-11
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Why Is Marvell Stock Up?
Why Is Marvell Stock Up?

Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
44
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
1
IONQ alert for Jan 10

IonQ [IONQ] is up 7.07% over the past day.

Sell
47
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
8
CRNX alert for Jan 11

Crinetics Pharmaceuticals [CRNX] is down 16.31% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock